Hematology

Filter

CAR-T Trial Access Lower for People With HIV

June 2026

People living with HIV face significantly longer travel times and reduced access to CAR-T clinical trials for non-Hodgkin lymphoma, with disparities most pronounced in the southern United States.

CAR-T Trial Access Lower for People With HIV

People living with HIV face significantly longer travel times and reduced access to CAR-T clinical trials for non-Hodgkin lymphoma, with disparities most pronounced in the southern United States.

Cellular therapy

EBMT Survey Reports Record Allogeneic Transplant Activity

The 2024 EBMT activity survey showed record allogeneic transplant numbers and continued expansion of CAR T therapy across Europe and affiliated countries.

VWF Biomarkers In Chronic GvHD - EMJ

Novel Biomarkers Identified for Chronic GvHD

Elevated von Willebrand factor and factor VIII levels demonstrated diagnostic potential and disease activity associations in chronic Graft-versus-Host Disease.

Venetoclax Regimen Improves Survival in Older Patients with AML

A venetoclax-based AML regimen produced high remission rates and prolonged survival in older or unfit patients with newly diagnosed acute myeloid leukaemia.

CRISPR Edited AML Transplant Shows Safe Engraftment

CRISPR Edited AML Transplant Shows Safe Engraftment

A gene edited AML transplant strategy achieved rapid engraftment and supported targeted maintenance therapy without prolonged high grade cytopenias in high risk disease.

hydroxyurea adherence

Hydroxyurea Adherence Declines Over Time in Sickle Cell Disease

Longitudinal data showed hydroxyurea adherence declined steadily among patients with sickle cell disease, particularly in older age groups and those with executive difficulties.

Targeting PELI1 In Chronic Myeloid Leukaemia

Targeting PELI1 in chronic myeloid leukaemia may overcome treatment resistance and eliminate leukaemia stem cells, offering a promising new therapeutic strategy.

TP53 Effects Vary in Myelodysplastic Neoplasms

TP53 Effects Vary in Myelodysplastic Neoplasms

TP53 multihit alterations show reduced impact in del(5q) myelodysplastic neoplasms, with improved survival and delayed progression to acute myeloid leukaemia.

Loading posts...

1 2 3 … 50 Next »